During the past decade, Centra Lynchburg Hematology-Oncology Clinic Inc conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 53 clinical trials were completed, i.e. on average, 96.4% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 30 clinical trials were completed. i.e. 136.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centra Lynchburg Hematology-Oncology Clinic Inc" #1 sponsor was "National Cancer Institute (NCI)" with 39 trials, followed by "SWOG Cancer Research Network" with 21 trials sponsored, "Alliance for Clinical Trials in Oncology" with 16 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored and "NSABP Foundation Inc" with 5 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centra Lynchburg Hematology-Oncology Clinic Inc" #1 collaborator was "National Cancer Institute (NCI)" with 52 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator and "Eastern Cooperative Oncology Group" with 5 trials as a collaborator. Other collaborators include 37 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Centra Lynchburg Hematology-Oncology Clinic Inc" are "Breast Cancer" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Stage IV Lung Cancer AJCC v8" (6 trials) and "HER2/Neu Negative" (5 trials). Many other conditions were trialed in "Centra Lynchburg Hematology-Oncology Clinic Inc" in a lesser frequency.

Most popular intervention types in "Centra Lynchburg Hematology-Oncology Clinic Inc" are "Drug" (92 trials), "Other" (62 trials), "Biological" (43 trials), "Procedure" (17 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (32 trials), "Quality-of-Life Assessment" (26 trials), "Questionnaire Administration" (13 trials), "Biospecimen Collection" (11 trials) and "Computed Tomography" (11 trials). Other intervention names were less common.

The vast majority of trials in "Centra Lynchburg Hematology-Oncology Clinic Inc" are 87 trials for "All" genders, 15 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Centra Lynchburg Hematology-Oncology Clinic Inc". undefined are not yet recruiting, 22 are recruiting, 43 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in Centra Lynchburg Hematology-Oncology Clinic Inc, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Centra Lynchburg Hematology-Oncology Clinic Inc, 1 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 79 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".